Literature DB >> 23687990

Experimental models for predicting drug absorption and metabolism.

Saeed Alqahtani1, Loqman A Mohamed, Amal Kaddoumi.   

Abstract

INTRODUCTION: For orally administered drugs, their intestinal absorption and hepatic metabolism are key players for determining a drug's systemic bioavailability and thus therapeutic effect. Drug absorption and metabolism are both complicated processes, with many physicochemical and physiological factors involved. Understanding the contribution of each of these processes is essential in regulating a drug's level in the bloodstream and in maintaining its optimum therapeutic outcome and safety. Several animal models have been established for studying the intestine and liver as barriers to drug delivery and systemic bioavailability. AREAS COVERED: This review provides an overview of available animal and cell-based models that have been used to characterize and predict drug intestinal absorption and hepatic clearance in humans. Among the most commonly used models to study drug intestinal absorption are in-vitro Caco-2 cells, in situ rat intestinal perfusion and the in vivo animal models. On the other hand, hepatic clearance is mostly studied using in vitro techniques. The authors also review in silico approaches which play significant role during early pharmaceutical research. EXPERT OPINION: The current models developed have greatly contributed to our knowledge of drug interactions with physiological factors, while also useful in the prediction of drug intestinal absorption and metabolism. However, much work remains in this area for the successful extrapolation of in vitro-in vivo data and in furthering the development of reliable and accurate models.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23687990     DOI: 10.1517/17425255.2013.802772

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  14 in total

1.  Using the BacMam Baculovirus System to Study Expression and Function of Recombinant Efflux Drug Transporters in Polarized Epithelial Cell Monolayers.

Authors:  King Leung Fung; Khyati Kapoor; Jessica N Pixley; Darrell J Talbert; Alexandra D T Kwit; Suresh V Ambudkar; Michael M Gottesman
Journal:  Drug Metab Dispos       Date:  2015-11-30       Impact factor: 3.922

2.  Prediction of hepatic drug clearance with a human microfluidic four-cell liver acinus microphysiology system.

Authors:  Courtney Sakolish; Yu-Syuan Luo; Alan Valdiviezo; Lawrence A Vernetti; Ivan Rusyn; Weihsueh A Chiu
Journal:  Toxicology       Date:  2021-09-17       Impact factor: 4.221

3.  Exploring the Carbamazepine Interaction with Human Pregnane X Receptor and Effect on ABCC2 Using in Vitro and in Silico Approach.

Authors:  Gurpreet K Grewal; Khuraijam D Singh; Neha Kanojia; Chitra Rawat; Samiksha Kukal; Ajay Jajodia; Anshika Singhal; Richa Misra; Selvaraman Nagamani; Karthikeyan Muthusamy; Ritushree Kukreti
Journal:  Pharm Res       Date:  2017-04-21       Impact factor: 4.200

4.  Characterizing drug-metabolizing enzymes and transporters that are bona fide CAR-target genes in mouse intestine.

Authors:  Shinhee Park; Sunny Lihua Cheng; Julia Yue Cui
Journal:  Acta Pharm Sin B       Date:  2016-08-02       Impact factor: 11.413

Review 5.  Application of multi-target phytotherapeutic concept in malaria drug discovery: a systems biology approach in biomarker identification.

Authors:  Protus Arrey Tarkang; Regina Appiah-Opong; Michael F Ofori; Lawrence S Ayong; Alexander K Nyarko
Journal:  Biomark Res       Date:  2016-12-13

Review 6.  Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions.

Authors:  Jean-Marie Nicolas; François Bouzom; Chanteux Hugues; Anna-Lena Ungell
Journal:  Biopharm Drug Dispos       Date:  2017-02-06       Impact factor: 1.627

7.  Bioprinted 3D Primary Human Intestinal Tissues Model Aspects of Native Physiology and ADME/Tox Functions.

Authors:  Lauran R Madden; Theresa V Nguyen; Salvador Garcia-Mojica; Vishal Shah; Alex V Le; Andrea Peier; Richard Visconti; Eric M Parker; Sharon C Presnell; Deborah G Nguyen; Kelsey N Retting
Journal:  iScience       Date:  2018-03-27

Review 8.  Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future.

Authors:  Jeffrey Cummings; Aaron Ritter; Kate Zhong
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 9.  Discovery and resupply of pharmacologically active plant-derived natural products: A review.

Authors:  Atanas G Atanasov; Birgit Waltenberger; Eva-Maria Pferschy-Wenzig; Thomas Linder; Christoph Wawrosch; Pavel Uhrin; Veronika Temml; Limei Wang; Stefan Schwaiger; Elke H Heiss; Judith M Rollinger; Daniela Schuster; Johannes M Breuss; Valery Bochkov; Marko D Mihovilovic; Brigitte Kopp; Rudolf Bauer; Verena M Dirsch; Hermann Stuppner
Journal:  Biotechnol Adv       Date:  2015-08-15       Impact factor: 14.227

10.  In Vitro Assessment of the Effect of Antiepileptic Drugs on Expression and Function of ABC Transporters and Their Interactions with ABCC2.

Authors:  Gurpreet Kaur Grewal; Samiksha Kukal; Neha Kanojia; Krateeka Madan; Luciano Saso; Ritushree Kukreti
Journal:  Molecules       Date:  2017-09-29       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.